Using sulfuramidimidoyl fluorides that undergo sulfur(vi) fluoride exchange for inverse drug discovery
- 30 August 2020
- journal article
- research article
- Published by Springer Science and Business Media LLC in Nature Chemistry
- Vol. 12 (10), 906-+
- https://doi.org/10.1038/s41557-020-0530-4
Abstract
Latent functional groups-typically unreactive unless activated by protein binding-can provide additional selectivity to covalent drugs. Now, compounds containing the weakly electrophilic sulfuramidimidoyl fluoride group, capable of undergoing sulfur(vi) fluoride exchange, have been used to identify reactive proteins in human cell lysate. This approach has identified a compound that conjugates to and inhibits an important anticancer target. Drug candidates that form covalent linkages with their target proteins have been underexplored compared with the conventional counterparts that modulate biological function by reversibly binding to proteins, in part due to concerns about off-target reactivity. However, toxicity linked to off-target reactivity can be minimized by using latent electrophiles that only become activated towards covalent bond formation on binding a specific protein. Here we study sulfuramidimidoyl fluorides, a class of weak electrophiles that undergo sulfur(vi) fluoride exchange chemistry. We show that equilibrium binding of a sulfuramidimidoyl fluoride to a protein can allow nucleophilic attack by a specific amino acid side chain, which leads to conjugate formation. We incubated small molecules, each bearing a sulfuramidimidoyl fluoride electrophile, with human cell lysate, and the protein conjugates formed were identified by affinity chromatography-mass spectrometry. This inverse drug discovery approach identified a compound that covalently binds to and irreversibly inhibits the activity of poly(ADP-ribose) polymerase 1, an important anticancer target in living cells.This publication has 50 references indexed in Scilit:
- SuFEx Click Chemistry Enabled Late-Stage Drug FunctionalizationJournal of the American Chemical Society, 2018
- “Inverse Drug Discovery” Strategy To Identify Proteins That Are Targeted by Latent Electrophiles As Exemplified by Aryl FluorosulfatesJournal of the American Chemical Society, 2017
- Bifluoride-catalysed sulfur(VI) fluoride exchange reaction for the synthesis of polysulfates and polysulfonatesNature Chemistry, 2017
- SuFEx‐Based Polysulfonate Formation from Ethenesulfonyl Fluoride–Amine AdductsAngewandte Chemie, 2017
- Arylfluorosulfates Inactivate Intracellular Lipid Binding Protein(s) through Chemoselective SuFEx Reaction with a Binding Site Tyr ResidueJournal of the American Chemical Society, 2016
- Covalent inhibitors in drug discovery: from accidental discoveries to avoided liabilities and designed therapiesDrug Discovery Today, 2015
- Sulfur(VI) Fluoride Exchange (SuFEx): Another Good Reaction for Click ChemistryAngewandte Chemie, 2014
- SuFEx‐Based Synthesis of PolysulfatesAngewandte Chemie, 2014
- The resurgence of covalent drugsNature Reviews Drug Discovery, 2011
- Impact of high-throughput screening in biomedical researchNature Reviews Drug Discovery, 2011